Kangstem Biotech Co. Ltd (217730) — Long-term Investment Intensity
Kangstem Biotech Co. Ltd (217730) has a Long-term Investment Intensity of 17.8% as of December 2019. Long-term investments of ₩20.23 Billion represent 17.8% of total assets of ₩113.64 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 217730 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Kangstem Biotech Co. Ltd Long-term Investment Intensity (2016–2019)
This chart shows how Kangstem Biotech Co. Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2016 to 2019. As of December 2019, the intensity stands at 17.8%, reflecting long-term investments of ₩20.23 Billion against total assets of ₩113.64 Billion KRW. For the complete balance sheet picture, see 217730 total assets.
Annual Long-term Investment Intensity for Kangstem Biotech Co. Ltd (2016–2019)
The table below presents the year-by-year Long-term Investment Intensity for Kangstem Biotech Co. Ltd from 2016 to 2019, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read debt load of Kangstem Biotech Co. Ltd for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 17.8% | ₩20.23 Billion | ₩113.64 Billion | ▲ +14.1 pp |
| 2018 | 3.7% | ₩2.72 Billion | ₩73.19 Billion | ▼ -1.4 pp |
| 2017 | 5.1% | ₩2.34 Billion | ₩45.91 Billion | ▲ +3.9 pp |
| 2016 | 1.2% | ₩568.82 Million | ₩47.44 Billion | — |